RxSight (RXST) Income towards Parent Company (2020 - 2026)
RxSight (RXST) posted Income towards Parent Company of -$15.9 million for Q1 2026, down 73.56% on a QoQ basis from -$9.2 million in Q4 2025, and down 93.94% year-over-year from -$262.3 million in Q1 2025.
RxSight (RXST) Income towards Parent Company (2020 - 2026) Analysis & Trends
RxSight's Income towards Parent Company history runs 7 years deep, the most recent figure standing at -$15.9 million for Q1 2026.
- Quarterly Income towards Parent Company fell 93.94% year-over-year to -$15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$46.6 million (down 76.31% YoY) and the FY2025 annual result came in at -$38.9 million, down 42.32% from the prior year.
- Income towards Parent Company was -$15.9 million for Q1 2026 at RxSight, down from -$9.2 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $53.5 million in Q4 2022 and bottomed at -$17.6 million in Q1 2022.
- A 5-year average of -$4.1 million and a median of -$9.8 million in 2025 frame the typical range for Income towards Parent Company.
- Peak annual rise in Income towards Parent Company reached 440.07% in 2022, while the deepest fall reached 158.57% in 2022.
- RxSight's Income towards Parent Company stood at $53.5 million in 2022, then slipped by 7.23% to $49.6 million in 2023, then plunged by 111.78% to -$5.8 million in 2024, then tumbled by 56.55% to -$9.2 million in 2025, then tumbled by 73.56% to -$15.9 million in 2026.
- Business Quant data shows RXST's Income towards Parent Company at -$15.9 million in Q1 2026, -$9.2 million in Q4 2025, and -$9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | RxSight | 226.56 Mn | -191.64 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.88 Mn |
| Dec 31, 2025 | -9.15 Mn |
| Sep 30, 2025 | -9.82 Mn |
| Jun 30, 2025 | -11.79 Mn |
| Mar 31, 2025 | -8.19 Mn |
| Dec 31, 2024 | -5.85 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | 49.64 Mn |
| Sep 30, 2023 | -12.42 Mn |
| Jun 30, 2023 | -13.80 Mn |
| Mar 31, 2023 | -13.21 Mn |
| Dec 31, 2022 | 53.51 Mn |
| Sep 30, 2022 | -16.82 Mn |
| Jun 30, 2022 | -16.73 Mn |
| Mar 31, 2022 | -17.60 Mn |
| Dec 31, 2021 | -15.73 Mn |
| Sep 30, 2021 | -12.67 Mn |
| Jun 30, 2021 | -13.48 Mn |